Medtronic PLC (MDT)
Profitability ratios
Return on sales
| Apr 30, 2025 | Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | |
|---|---|---|---|---|---|
| Gross profit margin | 0.00% | 65.34% | 25.96% | 65.67% | 25.79% |
| Operating profit margin | 17.76% | 15.89% | 15.61% | 17.56% | 17.40% |
| Pretax margin | 16.78% | 14.95% | 14.59% | 17.18% | 16.93% |
| Net profit margin | 13.90% | 11.36% | 11.15% | 12.03% | 11.92% |
Medtronic PLC's profitability ratios show fluctuations over the years. The gross profit margin varied significantly, dropping to 0% in April 30, 2025, but generally staying within a range of 25%-65%. The operating profit margin remained relatively stable around 15%-18% from April 28, 2023, to April 30, 2025. The pretax margin fluctuated, decreasing in April 26, 2024, before increasing again in April 30, 2025. The net profit margin displayed an upward trend over the years, increasing from 11.92% in April 28, 2023, to 13.90% in April 30, 2025. Overall, Medtronic PLC's profitability has shown some variability in margins, with a positive trend in net profit margin.
Return on investment
| Apr 30, 2025 | Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 6.50% | 5.72% | 5.72% | 6.03% | 6.03% |
| Return on assets (ROA) | 5.09% | 4.09% | 4.09% | 4.13% | 4.13% |
| Return on total capital | 0.00% | 11.06% | 11.01% | 11.22% | 8.16% |
| Return on equity (ROE) | 9.71% | 7.32% | 7.32% | 7.30% | 7.30% |
Medtronic PLC's profitability ratios exhibit varying trends over the years. The Operating Return on Assets (Operating ROA) remained relatively stable around 6% from April 2023 to April 2025, indicating consistent operational efficiency in generating profits from its assets. On the other hand, the Return on Assets (ROA) showed a slight increase from 4.13% in April 2023 to 5.09% in April 2025, suggesting an improvement in the company's overall ability to generate profits from its total assets.
The Return on Total Capital declined from 11.22% in April 2023 to 0.00% in April 2025, indicating a significant drop in the company's ability to generate returns for both debt and equity investors. However, it is essential to further investigate the reasons behind this sharp decrease.
Lastly, the Return on Equity (ROE) showed a slight increase from 7.30% in April 2023 to 9.71% in April 2025, demonstrating that the company's profitability in relation to shareholders' equity has improved over the years. Overall, while Medtronic PLC's profitability ratios show some mixed results, there are signs of improvement in terms of generating returns for both asset and equity investors.